{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:54:07Z","timestamp":1792065247089,"version":"4.4.0"},"reference-count":99,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"abstract":"<jats:p>\n                    Human gestation is characterized by dynamic changes in maternal physiology and maturation of tissue functions before and after birth. The fetus and neonate are highly dependent upon transfer of maternal nutrients via the placenta and lactating mammary gland, which frequently involve selective membrane transporter proteins. At the same time, developmental changes in fetal and infant transport mechanisms critical for regulating absorption at the intestinal and blood\u2013brain barriers are occurring. Coordinate regulation of cellular entry and efflux of nutrients, supplements, and xenobiotics, including drugs and environmental chemicals, must occur during this critical developmental period. In 2023, the National Institutes of Health launched the Transporter Elucidation Network (TEN) across four centers. This initiative applies experimental, computational, and translational approaches to (1) identify\n                    <jats:styled-content>S<\/jats:styled-content>\n                    o\n                    <jats:styled-content>L<\/jats:styled-content>\n                    ute\n                    <jats:styled-content>C<\/jats:styled-content>\n                    arrier (SLC) superfamily and\n                    <jats:styled-content>A<\/jats:styled-content>\n                    TP\u2010\n                    <jats:styled-content>b<\/jats:styled-content>\n                    inding\n                    <jats:styled-content>c<\/jats:styled-content>\n                    assette (ABC) transporters in the human placenta, mammary gland, as well as the pediatric brain and intestinal barriers and, (2) characterize their localization, expression, function, and regulation. The Network seeks to identify functional determinants of transporters as gatekeepers of entry to placenta, mammary gland and brain, and applies structural biology, proteomics, metabolomics, organoids, liquid biopsies, and microphysiological systems to this end. Computational strategies, such as machine learning, virtual screening, physiologically based pharmacokinetics, and perinatal epidemiology complement our experimental approaches. This paper highlights the TEN's multidisciplinary strategies to address current challenges in perinatal and pediatric transporter research and its commitment to advancing state\u2010of\u2010the\u2010art tools and new approach methodologies to fill critical gaps in our understanding of nutrient and xenobiotic exposure during early human development.\n                  <\/jats:p>","DOI":"10.1002\/cpt.70517","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:11:13Z","timestamp":1792062673000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Pregnancy and Pediatric Science through the\n                    <scp>NIH<\/scp>\n                    Transporter Elucidation Network"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-9101","authenticated-orcid":false,"given":"Joanne","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics School of Pharmacy University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-8455","authenticated-orcid":false,"given":"Jashvant D","family":"Unadkat","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics School of Pharmacy University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-2347","authenticated-orcid":false,"given":"Samuel LM","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics School of Pharmacy University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1848-0121","authenticated-orcid":false,"given":"John K","family":"Fallon","sequence":"additional","affiliation":[{"name":"Division of Pharmacoengineering and Molecular Pharmaceutics, and Center for Nanotechnology in Drug Delivery UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0812-5882","authenticated-orcid":false,"given":"Pouria","family":"Fattahi","sequence":"additional","affiliation":[{"name":"Department of Bioengineering School of Engineering and Applied Science, University of Pennsylvania  Philadelphia Pennsylvania USA"},{"name":"Regenerative Bioscience Center, School of Chemical, Materials and Biomedical Engineering University of Georgia  Athens Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5718-6884","authenticated-orcid":false,"given":"Dan Dongeun","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Bioengineering School of Engineering and Applied Science, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7078-8230","authenticated-orcid":false,"given":"Nicholas","family":"Ieronimakis","sequence":"additional","affiliation":[{"name":"Division of Clinical Investigation Madigan Army Medical Center  Tacoma Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6534-9313","authenticated-orcid":false,"given":"Edward J","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics School of Pharmacy University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-2587","authenticated-orcid":false,"given":"Svetlana","family":"Lutsenko","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pharmacology and Therapeutics The Johns Hopkins University School of Medicine  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-5665","authenticated-orcid":false,"given":"Robert M","family":"Stroud","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics University of California  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-1184","authenticated-orcid":false,"given":"Jacqueline B","family":"Tiley","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-4070","authenticated-orcid":false,"given":"Jia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Therapeutic Sciences University of California  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-0933","authenticated-orcid":false,"given":"Xujia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Therapeutic Sciences University of California  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-6129","authenticated-orcid":false,"given":"Hao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Center for Biomedical Informatics and Genomics, School of Medicine Tulane University  New Orleans Louisiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-5971","authenticated-orcid":false,"given":"Rajini","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pharmacology and Therapeutics The Johns Hopkins University School of Medicine  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-5430","authenticated-orcid":false,"given":"Kathleen M","family":"Giacomini","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Therapeutic Sciences University of California  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-1037","authenticated-orcid":false,"given":"Lauren M","family":"Aleksunes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology Ernest Mario School of Pharmacy, Rutgers University  Piscataway New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"e_1_2_11_1_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","article-title":"Membrane transporters in drug development and as determinants of precision medicine","volume":"23","author":"Galetin A.","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"Cesar\u2010Razquin A.","year":"2015","journal-title":"Cell"},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/mol.118.112482","article-title":"Organic cation transporter 3 facilitates fetal exposure to metformin during pregnancy","volume":"94","author":"Lee N.","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1515\/mr-2022-0025","article-title":"An update on placental drug transport and its relevance to fetal drug exposure","volume":"2021","author":"Mao Q.","year":"2022","journal-title":"Med. Rev."},{"key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev.nu.12.070192.001151","article-title":"Nutrient transport pathways across the epithelium of the placenta","volume":"12","author":"Smith C.H.","year":"1992","journal-title":"Annu. Rev. Nutr."},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.ajog.2004.07.059","article-title":"National Institute on Drug Abuse conference report on placental proteins, drug transport, and fetal development","volume":"191","author":"Thadani P.V.","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cpt.1516","article-title":"A comprehensive analysis of ontogeny of renal drug transporters: mRNA analyses, quantitative proteomics, and localization","volume":"106","author":"Cheung K.W.K.","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.64898\/2026.06.13.731200"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.64898\/2026.06.25.730994"},{"key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/toxsci\/kfy303","article-title":"Placental BCRP\/ABCG2 transporter prevents fetal exposure to the estrogenic mycotoxin zearalenone","volume":"168","author":"Szilagyi J.T.","year":"2019","journal-title":"Toxicol. Sci."},{"key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/17425255.2025.2461479","article-title":"Transporters and drug secretion into human breast milk","volume":"21","author":"Beers J.L.","year":"2025","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/s41390-025-04458-3","article-title":"Human milk: insights on cell composition, organoids and emerging applications","volume":"99","author":"Majood M.","year":"2025","journal-title":"Pediatr. Res."},{"key":"e_1_2_11_13_1","unstructured":"WHO.Perinatal Mortality Rate<https:\/\/www.who.int\/data\/gho\/indicator\u2010metadata\u2010registry\/imr\u2010details\/perinatal\u2010mortality\u2010rate>."},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0145-2134(87)90082-2","article-title":"The perinatal period, a window of opportunity for enhancing parent\u2010infant communication: an approach to prevention","volume":"11","author":"Helfer R.E.","year":"1987","journal-title":"Child Abuse Negl."},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","article-title":"Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling","volume":"51","author":"Abduljalil K.","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40262-018-0685-y","article-title":"Fetal physiologically based pharmacokinetic models: systems information on the growth and composition of fetal organs","volume":"58","author":"Abduljalil K.","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_2_11_17_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1440010","article-title":"The effect of pregnancy\u2010related hormones on hepatic transporters: studies with premenopausal human hepatocytes","volume":"15","author":"Benzi J.R.L.","year":"2024","journal-title":"Front. Pharmacol."},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P\u2010glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert M.F.","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_19_1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/dmd.121.000557","article-title":"Prediction of pregnancy\u2010induced changes in secretory and Total renal clearance of drugs transported by organic anion transporters","volume":"49","author":"Peng J.","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcph.6125","article-title":"In vivo activity of intestinal P\u2010glycoprotein and hepatic organic anion transporters polypeptide in pregnancy and postpartum","volume":"65","author":"Pego A.M.G.","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_2_11_21_1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.120.000067","article-title":"Gestational age\u2010dependent abundance of human placental transporters as determined by quantitative targeted proteomics","volume":"48","author":"Anoshchenko O.","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_22_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt.409","article-title":"Ontogeny of hepatic drug transporters as quantified by LC\u2010MS\/MS proteomics","volume":"100","author":"Prasad B.","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejps.2018.08.042","article-title":"Proteomics of human liver membrane transporters: a focus on fetuses and newborn infants","volume":"124","author":"Groen B.D.","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpt.176","article-title":"Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working group","volume":"98","author":"Brouwer K.L.","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-31224-6","article-title":"Proteomic profiling reveals age\u2010related changes in transporter proteins in the human blood\u2010brain barrier","volume":"16","author":"Zhou X.","year":"2025","journal-title":"Sci. Rep."},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2513928122","article-title":"Molecular mechanism of substrate transport by human peroxisomal ABCD3","volume":"122","author":"Gupta M.","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/clpt.2009.236","article-title":"The international transporter consortium: a collaborative group of scientists from academia, industry, and the FDA","volume":"87","author":"Huang S.M.","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cpt.2644","article-title":"Transporters in drug development: international transporter consortium update on emerging transporters of clinical importance","volume":"112","author":"Zamek\u2010Gliszczynski M.J.","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_29_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/d41573-020-00056-6","article-title":"The RESOLUTE consortium: unlocking SLC transporters for drug discovery","volume":"19","author":"Superti\u2010Furga G.","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"e_1_2_11_30_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s44320-025-00108-2","article-title":"Data\u2010 and knowledge\u2010derived functional landscape of human solute carriers","volume":"21","author":"Goldmann U.","year":"2025","journal-title":"Mol. Syst. Biol."},{"key":"e_1_2_11_31_1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s44320-025-00106-4","article-title":"Metabolic mapping of the human solute carrier superfamily","volume":"21","author":"Wiedmer T.","year":"2025","journal-title":"Mol. Syst. Biol."},{"key":"e_1_2_11_32_1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1124\/dmd.121.000702","article-title":"Emerging roles of the human solute carrier 22 family","volume":"50","author":"Yee S.W.","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_33_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008208","article-title":"Unraveling the functional role of the orphan solute carrier, SLC22A24 in the transport of steroid conjugates through metabolomic and genome\u2010wide association studies","volume":"15","author":"Yee S.W.","year":"2019","journal-title":"PLoS Genet."},{"key":"e_1_2_11_34_1","doi-asserted-by":"crossref","first-page":"15734","DOI":"10.1096\/fj.202001497R","article-title":"Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies","volume":"34","author":"Yee S.W.","year":"2020","journal-title":"FASEB J."},{"key":"e_1_2_11_35_1","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.1314939111","article-title":"OCT1 is a high\u2010capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin","volume":"111","author":"Chen L.","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"e_1_2_11_36_1","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1124\/dmd.109.028654","article-title":"Endogenous gene and protein expression of drug\u2010transporting proteins in cell lines routinely used in drug discovery programs","volume":"37","author":"Ahlin G.","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_37_1","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/QAD.0000000000001554","article-title":"Multimodal analysis of drug transporter expression in gastrointestinal tissue","volume":"31","author":"Thompson C.G.","year":"2017","journal-title":"AIDS"},{"key":"e_1_2_11_38_1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/acs.jproteome.9b00666","article-title":"Matrix\u2010matched calibration curves for assessing analytical figures of merit in quantitative proteomics","volume":"19","author":"Pino L.K.","year":"2020","journal-title":"J. Proteome Res."},{"key":"e_1_2_11_39_1","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41467-020-15346-1","article-title":"Generating high quality libraries for DIA MS with empirically corrected peptide predictions","volume":"11","author":"Searle B.C.","year":"2020","journal-title":"Nat. Commun."},{"key":"e_1_2_11_40_1","doi-asserted-by":"crossref","DOI":"10.1289\/EHP14478","article-title":"Mycoestrogen exposure during pregnancy: impact of the ABCG2 Q141K variant on birth and placental outcomes","volume":"133","author":"Rivera\u2010Nunez Z.","year":"2025","journal-title":"Environ. Health Perspect."},{"key":"e_1_2_11_41_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.xphs.2020.10.037","article-title":"Differential detergent fractionation of membrane protein from small samples of hepatocytes and liver tissue for quantitative proteomic analysis of drug metabolizing enzymes and transporters","volume":"110","author":"Qasem R.J.","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"e_1_2_11_42_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1004010","article-title":"Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes","volume":"13","author":"Fashe M.M.","year":"2022","journal-title":"Front. Pharmacol."},{"key":"e_1_2_11_43_1","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-025-05996-z","article-title":"Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic transporters","volume":"83","author":"Hartauer M.","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"e_1_2_11_44_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.placenta.2021.02.017","article-title":"Ex vivo dual perfusion of an isolated cotyledon of human placenta: history and future challenges","volume":"107","author":"Schneider H.","year":"2021","journal-title":"Placenta"},{"key":"e_1_2_11_45_1","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/jcph.2117","article-title":"Predicting human fetal drug exposure through maternal\u2010fetal PBPK modeling and in\u00a0vitro or ex\u00a0vivo studies","volume":"62","author":"Balhara A.","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_2_11_46_1","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/jcph.1491","article-title":"Drug transporters expressed in the human placenta and models for studying maternal\u2010fetal drug transfer","volume":"59","author":"Dallmann A.","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_2_11_47_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-55863-5","article-title":"Quantification and prediction of human fetal (\u2212)\u2010Delta(9)\u2010tetrahydrocannabinol\/(+\/\u2212)\u201011\u2010OH\u2010Delta(9)\u2010tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity","volume":"16","author":"Kumar A.R.","year":"2025","journal-title":"Nat. Commun."},{"key":"e_1_2_11_48_1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cpt.2964","article-title":"Understanding the mechanism and extent of transplacental transfer of (\u2212)\u2010\u2206(9) \u2010tetrahydrocannabinol (THC) in the perfused human placenta to predict in\u00a0vivo fetal THC exposure","volume":"114","author":"Kumar A.R.","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_49_1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s40262-017-0583-8","article-title":"Prediction of fetal darunavir exposure by integrating human ex\u2010vivo placental transfer and physiologically based pharmacokinetic modeling","volume":"57","author":"Schalkwijk S.","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_2_11_50_1","first-page":"e221","article-title":"Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach","volume":"232","author":"Van Der Heijden J.E.M.","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"e_1_2_11_51_1","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001551","article-title":"Human enteroid monolayers: a novel, functionally stable model for investigating oral drug disposition","volume":"53","author":"Arian C.","year":"2025","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_52_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107962","article-title":"Gutsy science: in\u00a0vitro systems of the human intestine to model oral drug disposition","volume":"230","author":"Arian C.M.","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"e_1_2_11_53_1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1023\/A:1015937605100","article-title":"Caco\u20102 cell monolayers as a model for drug transport across the intestinal mucosa","volume":"7","author":"Hilgers A.R.","year":"1990","journal-title":"Pharm. Res."},{"key":"e_1_2_11_54_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103597","article-title":"A gut response: application of human enteroid monolayers to probe the mechanism of the goldenseal\u2010mediated inhibition of metformin intestinal absorption","volume":"392","author":"Arian C.M.","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_11_55_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110510","article-title":"Leveraging RNA\u2010seq deconvolution to improve complex in\u00a0vitro model characterization","volume":"301","author":"Hansen B.C.","year":"2025","journal-title":"J. Biol. Chem."},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551\u2010026\u201001801\u20109"},{"key":"e_1_2_11_57_1","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.drudis.2020.07.005","article-title":"Advancing computer\u2010aided drug discovery (CADD) by big data and data\u2010driven machine learning modeling","volume":"25","author":"Zhao L.","year":"2020","journal-title":"Drug Discov. Today"},{"key":"e_1_2_11_58_1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-pharmtox-010919-023324","article-title":"Big data and artificial intelligence modeling for drug discovery","volume":"60","author":"Zhu H.","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"e_1_2_11_59_1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28165936","article-title":"Machine learning techniques applied to the study of drug transporters","volume":"28","author":"Kong X.","year":"2023","journal-title":"Molecules"},{"key":"e_1_2_11_60_1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1592\/phco.21.9.778.34558","article-title":"Pharmacokinetic and pharmacodynamic implications of P\u2010glycoprotein modulation","volume":"21","author":"Matheny C.J.","year":"2001","journal-title":"Pharmacotherapy"},{"key":"e_1_2_11_61_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2710.2003.00487.x","article-title":"Structure\u2010activity relationship: analyses of p\u2010glycoprotein substrates and inhibitors","volume":"28","author":"Wang R.B.","year":"2003","journal-title":"J. Clin. Pharm. Ther."},{"key":"e_1_2_11_62_1","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1021\/acs.jcim.0c00525","article-title":"Combining machine learning and molecular dynamics to predict P\u2010glycoprotein substrates","volume":"60","author":"Esposito C.","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"e_1_2_11_63_1","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1021\/acs.jmedchem.0c02047","article-title":"Identification of novel high\u2010affinity substrates of OCT1 using machine learning\u2010guided virtual screening and experimental validation","volume":"64","author":"Jensen O.","year":"2021","journal-title":"J. Med. Chem."},{"key":"e_1_2_11_64_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13321-015-0083-5","article-title":"Metrabase: a cheminformatics and bioinformatics database for small molecule transporter data analysis and (Q)SAR modeling","volume":"7","author":"Mak L.","year":"2015","journal-title":"J. Cheminform."},{"key":"e_1_2_11_65_1","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1023\/B:PHAM.0000048207.11160.d0","article-title":"Transporter database, TP\u2010search: a web\u2010accessible comprehensive database for research in pharmacokinetics of drugs","volume":"21","author":"Ozawa N.","year":"2004","journal-title":"Pharm. Res."},{"key":"e_1_2_11_66_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/clpt.2012.44","article-title":"The UCSF\u2010FDA TransPortal: a public drug transporter database","volume":"92","author":"Morrissey K.M.","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_67_1","doi-asserted-by":"crossref","first-page":"D461","DOI":"10.1093\/nar\/gkaa1004","article-title":"The transporter classification database (TCDB): 2021 update","volume":"49","author":"Saier M.H.","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"e_1_2_11_68_1","doi-asserted-by":"crossref","first-page":"D1490","DOI":"10.1093\/nar\/gkad818","article-title":"VARIDT 3.0: the phenotypic and regulatory variability of drug transporter","volume":"52","author":"Yin J.","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"e_1_2_11_69_1","doi-asserted-by":"crossref","first-page":"W213","DOI":"10.1093\/nar\/gkaf343","article-title":"DeepMolecules: a web server for predicting enzyme and transporter\u2010small molecule interactions","volume":"53","author":"Kroll A.","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"e_1_2_11_70_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109148","article-title":"Drug\u2010drug interactions prediction based on deep learning and knowledge graph: a review","volume":"27","author":"Luo H.","year":"2024","journal-title":"iScience"},{"key":"e_1_2_11_71_1","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1021\/acs.jcim.4c00921","article-title":"Prediction of inhibitory activity against the MATE1 transporter via combined fingerprint\u2010 and physics\u2010based machine learning models","volume":"64","author":"Handa K.","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"e_1_2_11_72_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12859-025-06051-1","article-title":"A hybrid machine learning framework for functional annotation of mitochondrial glutathione transport and metabolism proteins in cancers","volume":"26","author":"Kennedy L.","year":"2025","journal-title":"BMC Bioinformatics"},{"key":"e_1_2_11_73_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1498945","article-title":"MONSTROUS: a web\u2010based chemical\u2010transporter interaction profiler","volume":"16","author":"AbdulHameed M.D.M.","year":"2025","journal-title":"Front. Pharmacol."},{"key":"e_1_2_11_74_1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11095-013-1222-1","article-title":"Critical evaluation of human oral bioavailability for pharmaceutical drugs by using various cheminformatics approaches","volume":"31","author":"Kim M.T.","year":"2014","journal-title":"Pharm. Res."},{"key":"e_1_2_11_75_1","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s11095-015-1687-1","article-title":"Developing enhanced blood\u2010brain barrier permeability models: integrating external bio\u2010assay data in QSAR modeling","volume":"32","author":"Wang W.","year":"2015","journal-title":"Pharm. Res."},{"key":"e_1_2_11_76_1","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1021\/acs.molpharmaceut.5c01065","article-title":"Machine learning modeling for ABC transporter efflux and inhibition: data curation, model development, and new compound interaction predictions","volume":"22","author":"Daood N.J.","year":"2025","journal-title":"Mol. Pharm."},{"key":"e_1_2_11_77_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.121.000538","article-title":"Successful prediction of human fetal exposure to P\u2010glycoprotein substrate drugs using the proteomics\u2010informed relative expression factor approach and PBPK modeling and simulation","volume":"49","author":"Anoshchenko O.","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_78_1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cpt.3157","article-title":"Successful prediction of fetal exposure to dual BCRP\/P\u2010gp drug substrates using the efflux ratio\u2010relative expression factor approach and PBPK M&S","volume":"115","author":"Balhara A.","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_79_1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/dmd.112.050161","article-title":"A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women","volume":"41","author":"Ke A.B.","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_80_1","article-title":"A PBPK model to predict disposition of CYP3A\u2010metabolized drugs in pregnant women: verification and discerning the site of CYP3A induction","volume":"1","author":"Ke A.B.","year":"2012","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"e_1_2_11_81_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bcp.12207","article-title":"Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19","volume":"77","author":"Ke A.B.","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_2_11_82_1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/dmd.116.073957","article-title":"Development of a novel maternal\u2010fetal physiologically based pharmacokinetic model II: verification of the model for passive placental permeability drugs","volume":"45","author":"Zhang Z.","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_11_83_1","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMra1704286","article-title":"Circulating extracellular vesicles in human disease","volume":"379","author":"Shah R.","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"e_1_2_11_84_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Niel G.","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"e_1_2_11_85_1","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1600227","article-title":"Extracellular vesicles as vital players in drug delivery: a focus on clinical disease treatment","volume":"13","author":"Chen T.","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"e_1_2_11_86_1","first-page":"251","article-title":"Extracellular vesicles: function, resilience, biomarker, bioengineering, and clinical implications","volume":"36","author":"Sun D.S.","year":"2024","journal-title":"Tzu Chi Med. J."},{"key":"e_1_2_11_87_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/cpt.2244","article-title":"Exploring the use of serum\u2010derived small extracellular vesicles as liquid biopsy to study the induction of hepatic cytochromes P450 and organic anion transporting polypeptides","volume":"110","author":"Rodrigues A.D.","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_88_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cpt.2440","article-title":"Leveraging human plasma\u2010derived small extracellular vesicles as liquid biopsy to study the induction of cytochrome P450 3A4 by modafinil","volume":"111","author":"Rodrigues A.D.","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_11_89_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcp.13793","article-title":"Plasma extracellular nanovesicle (exosome)\u2010derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure","volume":"85","author":"Rowland A.","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa009"},{"key":"e_1_2_11_91_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2018.08.004","article-title":"Cell\u2010 and size\u2010specific analysis of placental extracellular vesicles in maternal plasma and pre\u2010eclampsia","volume":"201","author":"Morgan T.K.","year":"2018","journal-title":"Transl. Res."},{"key":"e_1_2_11_92_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115597","article-title":"Protective role of the placental efflux transporter BCRP\/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth","volume":"225","author":"Barrett E.S.","year":"2023","journal-title":"Environ. Res."},{"key":"e_1_2_11_93_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.placenta.2025.10.011","article-title":"Maternal organophosphate pesticide exposure in relation to birthweight: modification by placenta transporter genotype","volume":"172","author":"Nguyen D.Q.","year":"2025","journal-title":"Placenta"},{"key":"e_1_2_11_94_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044798","article-title":"Cohort profile: understanding pregnancy signals and infant development (UPSIDE): a pregnancy cohort study on prenatal exposure mechanisms for child health","volume":"11","author":"O'Connor T.","year":"2021","journal-title":"BMJ Open"},{"key":"e_1_2_11_95_1","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.46","article-title":"DASH, the data and specimen hub of the National Institute of Child Health and Human Development","volume":"5","author":"Hazra R.","year":"2018","journal-title":"Sci. Data"},{"key":"e_1_2_11_96_1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41390-021-01574-8","article-title":"The NIH ECHO program: investigating how early environmental influences affect child health","volume":"92","author":"Blaisdell C.J.","year":"2022","journal-title":"Pediatr. Res."},{"key":"e_1_2_11_97_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.placenta.2021.07.294","article-title":"The global pregnancy collaboration (CoLab) biobank of rare placentas","volume":"114","author":"Makin J.","year":"2021","journal-title":"Placenta"},{"key":"e_1_2_11_98_1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/jp.2016.130","article-title":"Generation and validation of a universal perinatal database and biospecimen repository: PeriBank","volume":"36","author":"Antony K.M.","year":"2016","journal-title":"J. Perinatol."},{"key":"e_1_2_11_99_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2024.101304","article-title":"Facilitating global collaborations for pregnancy and pediatric biomarker research through a biobank database: the Collaborative Online Perinatal & Pediatric Repository project","volume":"6","author":"Faysal H.","year":"2024","journal-title":"Am J Obstet Gynecol MFM"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70517","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.70517","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:11:23Z","timestamp":1792062683000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":99,"alternative-id":["10.1002\/cpt.70517"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70517","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"2026-06-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"cpt.70517"}}